KAREN INZURRIAGA: Open Payments
NPI 1285177659 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 7 payments from 5 companies in 2025. Trend: 2023 $1,518 · 2024 $917 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $141 |
| ABIOMED | 2 | $137 |
| ABBVIE INC. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: UZEDY, VRAYLAR, ABILIFY ASIMTUFII, COBENFY.
Industry payments across TX — which companies pay providers there.
